<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article176</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index_gpt.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/SAFE" style="display:block; margin-bottom:10px;">SAFE Original</a></li>
<h2><strong>SAFE</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>
<br/>
<br/>
<h2><strong>Contents</strong></h2><br/>
1 Clinical Question<br/>
2 Bottom Line<br/>
3 Major Points<br/>
4 Guidelines<br/>
5 Design<br/>
6 Population<br/>
6.1 Inclusion Criteria<br/>
6.2 Exclusion Criteria<br/>
6.3 Baseline Characteristics<br/>
7 Interventions<br/>
8 Outcomes<br/>
8.1 Primary Outcome<br/>
8.2 Secondary Outcomes<br/>
9 Funding<br/>
10 Further Reading<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
In ICU patients requiring intravascular volume resuscitation, does the choice of resuscitation fluid (albumin or saline) affect survival?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
In ICU patients requiring fluid resuscitation, there is no significant difference in 28-day mortality rates between those treated with albumin and those treated with saline.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/><br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/><br/>
<br/>
<h2><strong>Design</strong></h2><br/>
Multicenter, double-blind, parallel group, randomized, placebo-controlled trial<br/>
N=6,997<br/>
Albumin group (n=3,497)<br/>
Saline group (n=3,500)<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
Inclusion Criteria: ICU patients 18 years or older requiring fluid administration to maintain or increase intravascular volume.<br/>
Exclusion Criteria: Patients admitted post-cardiac surgery, post-liver transplantation, or for treatment of burns.<br/>
Baseline Characteristics: Similar baseline characteristics between both groups, including APACHE II scores and organ failure assessment.<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
Patients were randomized to receive either 4% albumin or normal saline for intravascular fluid resuscitation in the 28 days following randomization.<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
Primary Outcome: Death from any cause within 28 days of randomization.<br/>
Secondary Outcomes: Duration of mechanical ventilation, duration of renal-replacement therapy, length of ICU and hospital stay, rate of new single-organ, and multiple-organ failure.<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
Supported by multiple health boards, departments, councils, and CSL (manufacturers of Albumex).<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
The full text is available from the The New England Journal of Medicine as linked in the original article.
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
